Selected research
Industry Research
External Anti-infective Preparations Industry Research Report 2026
Market perspective
The global External Anti-infective Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the External Anti-infective Preparations market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the External Anti-infective Preparations market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the External Anti-infective Preparations market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of External Anti-infective Preparations include SK-SF, Zhejiang Funo Pharmaceuticals, Teva, Sun Pharmaceutical, Shandong Jingwei Pharmaceuticals, Sandoz, J & J, Liaoning Xingao Pharmaceuticals and Jiangsu Zhiyuan Pharmaceuticals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global External Anti-infective Preparations market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to External Anti-infective Preparations.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
External Anti-infective Preparations Market by Company
SK-SF
Zhejiang Funo Pharmaceuticals
Teva
Sun Pharmaceutical
Shandong Jingwei Pharmaceuticals
Sandoz
J & J
Liaoning Xingao Pharmaceuticals
Jiangsu Zhiyuan Pharmaceuticals
Jiangsu Fubang Pharmaceuticals
Hubei Renfu
Bayer
STADA Arzneimittel
LEO Pharma
Kaken Pharmaceutical
Haleon
Glenmark Pharmaceuticals
Galderma
Bausch Health
Almirall
External Anti-infective Preparations Segment by Type
Ointment
Solution
Gel
Other
External Anti-infective Preparations Segment by Application
Hospital
Retail Phamracy
Other
External Anti-infective Preparations Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anti-infective Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of External Anti-infective Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anti-infective Preparations.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of External Anti-infective Preparations companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointment
- Solution
- Gel
- Other
Applications
- Hospital
- Retail Phamracy
- Other
Companies covered
- SK-SF
- Zhejiang Funo Pharmaceuticals
- Teva
- Sun Pharmaceutical
- Shandong Jingwei Pharmaceuticals
- Sandoz
- J & J
- Liaoning Xingao Pharmaceuticals
- Jiangsu Zhiyuan Pharmaceuticals
- Jiangsu Fubang Pharmaceuticals
- Hubei Renfu
- Bayer
- STADA Arzneimittel
- LEO Pharma
- Kaken Pharmaceutical
- Haleon
- Glenmark Pharmaceuticals
- Galderma
- Bausch Health
- Almirall
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 External Anti-infective Preparations by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ointment
- 2.2.3 Solution
- 2.2.4 Gel
- 2.2.5 Other
- 2.3 External Anti-infective Preparations by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Phamracy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 External Anti-infective Preparations Breakdown Data by Type
- 3.1 Global External Anti-infective Preparations Historic Market Size by Type (2021-2026)
- 3.2 Global External Anti-infective Preparations Forecasted Market Size by Type (2027-2032)
4 External Anti-infective Preparations Breakdown Data by Application
- 4.1 Global External Anti-infective Preparations Historic Market Size by Application (2021-2026)
- 4.2 Global External Anti-infective Preparations Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global External Anti-infective Preparations Market Perspective (2021-2032)
- 5.2 Global External Anti-infective Preparations Growth Trends by Region
- 5.2.1 Global External Anti-infective Preparations Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 External Anti-infective Preparations Historic Market Size by Region (2021-2026)
- 5.2.3 External Anti-infective Preparations Forecasted Market Size by Region (2027-2032)
- 5.3 External Anti-infective Preparations Market Dynamics
- 5.3.1 External Anti-infective Preparations Industry Trends
- 5.3.2 External Anti-infective Preparations Market Drivers
- 5.3.3 External Anti-infective Preparations Market Challenges
- 5.3.4 External Anti-infective Preparations Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top External Anti-infective Preparations Players by Revenue
- 6.1.1 Global Top External Anti-infective Preparations Players by Revenue (2021-2026)
- 6.1.2 Global External Anti-infective Preparations Revenue Market Share by Players (2021-2026)
- 6.2 Global External Anti-infective Preparations Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of External Anti-infective Preparations Head Office and Area Served
- 6.4 Global External Anti-infective Preparations Players, Product Type & Application
- 6.5 Global External Anti-infective Preparations Manufacturers Established Date
- 6.6 Global External Anti-infective Preparations Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America External Anti-infective Preparations Market Size (2021-2032)
- 7.2 North America External Anti-infective Preparations Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America External Anti-infective Preparations Market Size by Country (2021-2026)
- 7.4 North America External Anti-infective Preparations Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe External Anti-infective Preparations Market Size (2021-2032)
- 8.2 Europe External Anti-infective Preparations Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe External Anti-infective Preparations Market Size by Country (2021-2026)
- 8.4 Europe External Anti-infective Preparations Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific External Anti-infective Preparations Market Size (2021-2032)
- 9.2 Asia-Pacific External Anti-infective Preparations Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific External Anti-infective Preparations Market Size by Country (2021-2026)
- 9.4 Asia-Pacific External Anti-infective Preparations Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America External Anti-infective Preparations Market Size (2021-2032)
- 10.2 South America External Anti-infective Preparations Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America External Anti-infective Preparations Market Size by Country (2021-2026)
- 10.4 South America External Anti-infective Preparations Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa External Anti-infective Preparations Market Size (2021-2032)
- 11.2 Middle East & Africa External Anti-infective Preparations Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa External Anti-infective Preparations Market Size by Country (2021-2026)
- 11.4 Middle East & Africa External Anti-infective Preparations Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SK-SF
- 12.1.1 SK-SF Company Information
- 12.1.2 SK-SF Business Overview
- 12.1.3 SK-SF Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.1.4 SK-SF External Anti-infective Preparations Product Portfolio
- 12.1.5 SK-SF Recent Developments
- 12.2 Zhejiang Funo Pharmaceuticals
- 12.2.1 Zhejiang Funo Pharmaceuticals Company Information
- 12.2.2 Zhejiang Funo Pharmaceuticals Business Overview
- 12.2.3 Zhejiang Funo Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.2.4 Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.2.5 Zhejiang Funo Pharmaceuticals Recent Developments
- 12.3 Teva
- 12.3.1 Teva Company Information
- 12.3.2 Teva Business Overview
- 12.3.3 Teva Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.3.4 Teva External Anti-infective Preparations Product Portfolio
- 12.3.5 Teva Recent Developments
- 12.4 Sun Pharmaceutical
- 12.4.1 Sun Pharmaceutical Company Information
- 12.4.2 Sun Pharmaceutical Business Overview
- 12.4.3 Sun Pharmaceutical Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.4.4 Sun Pharmaceutical External Anti-infective Preparations Product Portfolio
- 12.4.5 Sun Pharmaceutical Recent Developments
- 12.5 Shandong Jingwei Pharmaceuticals
- 12.5.1 Shandong Jingwei Pharmaceuticals Company Information
- 12.5.2 Shandong Jingwei Pharmaceuticals Business Overview
- 12.5.3 Shandong Jingwei Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.5.4 Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.5.5 Shandong Jingwei Pharmaceuticals Recent Developments
- 12.6 Sandoz
- 12.6.1 Sandoz Company Information
- 12.6.2 Sandoz Business Overview
- 12.6.3 Sandoz Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.6.4 Sandoz External Anti-infective Preparations Product Portfolio
- 12.6.5 Sandoz Recent Developments
- 12.7 J & J
- 12.7.1 J & J Company Information
- 12.7.2 J & J Business Overview
- 12.7.3 J & J Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.7.4 J & J External Anti-infective Preparations Product Portfolio
- 12.7.5 J & J Recent Developments
- 12.8 Liaoning Xingao Pharmaceuticals
- 12.8.1 Liaoning Xingao Pharmaceuticals Company Information
- 12.8.2 Liaoning Xingao Pharmaceuticals Business Overview
- 12.8.3 Liaoning Xingao Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.8.4 Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.8.5 Liaoning Xingao Pharmaceuticals Recent Developments
- 12.9 Jiangsu Zhiyuan Pharmaceuticals
- 12.9.1 Jiangsu Zhiyuan Pharmaceuticals Company Information
- 12.9.2 Jiangsu Zhiyuan Pharmaceuticals Business Overview
- 12.9.3 Jiangsu Zhiyuan Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.9.4 Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.9.5 Jiangsu Zhiyuan Pharmaceuticals Recent Developments
- 12.10 Jiangsu Fubang Pharmaceuticals
- 12.10.1 Jiangsu Fubang Pharmaceuticals Company Information
- 12.10.2 Jiangsu Fubang Pharmaceuticals Business Overview
- 12.10.3 Jiangsu Fubang Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.10.4 Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.10.5 Jiangsu Fubang Pharmaceuticals Recent Developments
- 12.11 Hubei Renfu
- 12.11.1 Hubei Renfu Company Information
- 12.11.2 Hubei Renfu Business Overview
- 12.11.3 Hubei Renfu Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.11.4 Hubei Renfu External Anti-infective Preparations Product Portfolio
- 12.11.5 Hubei Renfu Recent Developments
- 12.12 Bayer
- 12.12.1 Bayer Company Information
- 12.12.2 Bayer Business Overview
- 12.12.3 Bayer Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.12.4 Bayer External Anti-infective Preparations Product Portfolio
- 12.12.5 Bayer Recent Developments
- 12.13 STADA Arzneimittel
- 12.13.1 STADA Arzneimittel Company Information
- 12.13.2 STADA Arzneimittel Business Overview
- 12.13.3 STADA Arzneimittel Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.13.4 STADA Arzneimittel External Anti-infective Preparations Product Portfolio
- 12.13.5 STADA Arzneimittel Recent Developments
- 12.14 LEO Pharma
- 12.14.1 LEO Pharma Company Information
- 12.14.2 LEO Pharma Business Overview
- 12.14.3 LEO Pharma Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.14.4 LEO Pharma External Anti-infective Preparations Product Portfolio
- 12.14.5 LEO Pharma Recent Developments
- 12.15 Kaken Pharmaceutical
- 12.15.1 Kaken Pharmaceutical Company Information
- 12.15.2 Kaken Pharmaceutical Business Overview
- 12.15.3 Kaken Pharmaceutical Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.15.4 Kaken Pharmaceutical External Anti-infective Preparations Product Portfolio
- 12.15.5 Kaken Pharmaceutical Recent Developments
- 12.16 Haleon
- 12.16.1 Haleon Company Information
- 12.16.2 Haleon Business Overview
- 12.16.3 Haleon Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.16.4 Haleon External Anti-infective Preparations Product Portfolio
- 12.16.5 Haleon Recent Developments
- 12.17 Glenmark Pharmaceuticals
- 12.17.1 Glenmark Pharmaceuticals Company Information
- 12.17.2 Glenmark Pharmaceuticals Business Overview
- 12.17.3 Glenmark Pharmaceuticals Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.17.4 Glenmark Pharmaceuticals External Anti-infective Preparations Product Portfolio
- 12.17.5 Glenmark Pharmaceuticals Recent Developments
- 12.18 Galderma
- 12.18.1 Galderma Company Information
- 12.18.2 Galderma Business Overview
- 12.18.3 Galderma Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.18.4 Galderma External Anti-infective Preparations Product Portfolio
- 12.18.5 Galderma Recent Developments
- 12.19 Bausch Health
- 12.19.1 Bausch Health Company Information
- 12.19.2 Bausch Health Business Overview
- 12.19.3 Bausch Health Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.19.4 Bausch Health External Anti-infective Preparations Product Portfolio
- 12.19.5 Bausch Health Recent Developments
- 12.20 Almirall
- 12.20.1 Almirall Company Information
- 12.20.2 Almirall Business Overview
- 12.20.3 Almirall Revenue in External Anti-infective Preparations Business (2021-2026)
- 12.20.4 Almirall External Anti-infective Preparations Product Portfolio
- 12.20.5 Almirall Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst